Juraj Kóňa

Juraj Kóňa

Auto-generated profile, based on publicly available information

Juraj Kóňa

Institute of Chemistry, Center for Glycomics, Slovak Academy of Sciences, Dúbravska cesta 9, 845 38 Bratislava, Slovakia

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2012 in ACS Nano
Verified
Journal Article
Closed access
DBDavide Brambilla
Davide Brambilla
RVRomain Verpillot
Romain Verpillot
BDBenjamin Le Droumaguet
Benjamin Le Droumaguet
JNJulien Nicolas
Julien Nicolas
MTMyriam Taverna
Myriam Taverna
KAKarine Andrieux
Karine Andrieux

14 January 2023 in Cells
Verified
Journal Article
Open access
PDF file
ITIgor Tvaroška
Igor Tvaroška
SKStanislav Kozmon
Stanislav Kozmon
JKJuraj Kóňa
Juraj Kóňa
Integrins are heterodimeric glycoproteins crucial to the physiology and pathology of many biological functions. As adhesion molecules, they mediate immune cell trafficking, migration, and immunological synapse formation during inflammation and cancer. The recognition of the vital roles of integrins in various diseases revealed their therapeutic potential. Despite the great effort in the last thirty years, up to now, only seven integrin-based drugs have entered the market. Recent progress in deciphering integrin functions, signaling, and interactions with ligands, along with advancement in rational drug design strategies, provide an opportunity to exploit their therapeutic potential and discover novel agents. This review will discuss the molecular modeling methods used in determining integrins’ dynamic properties and in providing information toward understanding their properties and function at the atomic level. Then, we will survey the relevant contributions and the current understanding of integrin structure, activation, the binding of essential ligands, and the role of molecular modeling methods in the rational design of antagonists. We will emphasize the role played by molecular modeling methods in progress in these areas and the designing of integrin antagonists.

17 April 2014 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
ABAdela Bobovská
Adela Bobovská
ITIgor Tvaroška
Igor Tvaroška
JKJuraj Kóňa
Juraj Kóňa
Glycosyltransferases are sugar-processing enzymes that require a specific metal ion cofactor for catalysis. In the presence of other ions the catalysis is often impaired. Here, for the first time, the enzymatic catalysis in the presence of various metal ions was modeled for a glycosyltransferase using a large enzymatic model. The catalytic mechanism of α-1,2-mannosyltransferase Kre2p/Mnt1p in the presence of Mn2+ and other ions (Mg2+, Zn2+ and Ca2+) was modeled at the two hybrid DFT-QM/MM (M06-2X/OPLS2005 and B3LYP/OPLS2005) levels. Kinetic and structural parameters of transition states and intermediates, as well as kinetic isotope effects, were predicted and compared with available experimental and theoretical data. The catalysis in the presence of the metal ions is predicted as a stepwise SNi-like nucleophilic substitution reaction (DNint*AN ‡DhAxh) via oxocarbenium ion intermediates. In the rate-determining step the leaving phosphate group of the donor substrate plays a role of the base catalyst. The predicted increased enzymatic reactivity (kcat: Zn2+ ≈ Mg2+ < Mn2+ < Ca2+) correlated with the metal ion ability to polarize the Kre2p environment (Mg2+ > Zn2+ > Mn2+ > Ca2+). The formation of the retained anomeric configuration in the product is controlled by a strict geometry of the active site of Kre2p. The 6-OH group of the attacking acceptor substrate may assist in protection of the anomeric carbon against unwanted hydrolysis by a through-space interaction with the electron deficient C1O5+ moiety of the oxocarbenium-ion-like transition state.


1 March 2011 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MPMonika Polakova
Monika Polakova
SŠSergej Šesták
Sergej Šesták
ELErika Lattová
Erika Lattová
LPLadislav Petruš
Ladislav Petruš
JMJán Mucha
Ján Mucha
JKJuraj Kóňa
Juraj Kóňa

11 January 2018 in ChemMedChem
Verified
Journal Article
Closed access
PDF file
SŠSergej Šesták
Sergej Šesták
MBMaros Bella
Maros Bella
TKTomáš Klunda
Tomáš Klunda
SGSoňa Gurská
Soňa Gurská
PDPetr Džubák
Petr Džubák
JKJuraj Kóňa
Juraj Kóňa